Blurbs

Analysts’ Top Healthcare Picks: Mirati Therapeutics (MRTX), AbCellera Biologics (ABCL)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mirati Therapeutics (MRTXResearch Report), AbCellera Biologics (ABCLResearch Report) and Beauty Health (SKINResearch Report) with bullish sentiments.

Mirati Therapeutics (MRTX)

SVB Securities analyst Andrew Berens maintained a Buy rating on Mirati Therapeutics today and set a price target of $102.00. The company’s shares closed last Tuesday at $59.44.

According to TipRanks.com, Berens is a 4-star analyst with an average return of 3.6% and a 46.1% success rate. Berens covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Zentalis Pharmaceuticals, and Theseus Pharmaceuticals.

Mirati Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $98.50, which is a 64.1% upside from current levels. In a report issued on November 4, BMO Capital also maintained a Buy rating on the stock with a $110.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

AbCellera Biologics (ABCL)

In a report released today, Puneet Souda from SVB Securities maintained a Buy rating on AbCellera Biologics, with a price target of $20.00. The company’s shares closed last Tuesday at $12.24.

According to TipRanks.com, Souda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -12.0% and a 36.1% success rate. Souda covers the Healthcare sector, focusing on stocks such as Castle Biosciences, Twist Bioscience, and Myriad Genetics.

Currently, the analyst consensus on AbCellera Biologics is a Strong Buy with an average price target of $34.20, a 185.0% upside from current levels. In a report issued on November 2, Berenberg Bank also maintained a Buy rating on the stock with a $43.00 price target.

Beauty Health (SKIN)

In a report released today, Linda Bolton Weiser from D.A. Davidson maintained a Buy rating on Beauty Health, with a price target of $32.00. The company’s shares closed last Tuesday at $10.70, close to its 52-week low of $9.79.

According to TipRanks.com, Weiser is a 3-star analyst with an average return of 0.7% and a 46.2% success rate. Weiser covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, Waldencast Acquisition, and 1-800 Flowers.

Beauty Health has an analyst consensus of Strong Buy, with a price target consensus of $21.38.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MRTX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More